APAIIF 亞太人工智能產業總會APAIIFAI Knowledge

AI in Healthcare

Discover AI applications and innovations in healthcare

10 articles

Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

Scan.com Closes $220M Financing: AI Agents Revolutionize Medical Imaging Scheduling as 85% of Scans Still Booked by Fax

Scan.com closes $220M in combined equity and debt financing with annualized revenue exceeding $165M. The company uses AI agent technology to revolutionize medical imaging scheduling, addressing the U.S. market where 85% of scans are still booked by fax, having served over 900,000 patients globally.

Sep 3, 20265
FedEHR-Agents and CareGraph: Federated Learning AI Agents Revolutionize Clinical EHR Modeling, Enabling Cross-Hospital Knowledge Sharing While Protecting Patient Privacy

FedEHR-Agents and CareGraph: Federated Learning AI Agents Revolutionize Clinical EHR Modeling, Enabling Cross-Hospital Knowledge Sharing While Protecting Patient Privacy

FedEHR-Agents replaces model parameters with 'clinical modeling experience' as the federated learning collaborative object, enabling cross-hospital knowledge sharing while strictly protecting patient data; CareGraph provides auditable hybrid AI health intelligence, avoiding overly autonomous clinical decision-making.

Sep 2, 20264
Chai Discovery Closes $400M Series C: Chai-3 Doubles Antibody Design Success Rate, Eli Lilly, Pfizer, and Novartis Back AI Drug Discovery Star

Chai Discovery Closes $400M Series C: Chai-3 Doubles Antibody Design Success Rate, Eli Lilly, Pfizer, and Novartis Back AI Drug Discovery Star

Chai Discovery closed a $400M Series C in July 2026, reaching a $3.8B valuation. The Chai-3 model doubles antibody design success rates with two-week validation cycles, securing strategic partnerships with Eli Lilly, Pfizer, and Novartis, signaling AI drug discovery's commercial maturity.

Sep 1, 20264
Pew Research Survey: 72% of Americans Demand Mandatory Healthcare AI Disclosure, Public Trust Drops from 52% to 42%, Healthcare AI Faces Transparency Crisis

Pew Research Survey: 72% of Americans Demand Mandatory Healthcare AI Disclosure, Public Trust Drops from 52% to 42%, Healthcare AI Faces Transparency Crisis

Pew Research Center published a new survey on August 25, 2026, showing 72% of American adults believe healthcare providers must mandatorily disclose AI use, with over 80% wanting notification when AI analyzes medical scans or makes diagnoses. Meanwhile, public acceptance of healthcare AI dropped from 52% in 2024 to 42% in April 2026, with 53% of respondents saying they have little to no say in AI's use in their care.

Aug 31, 20264
Shocking Healthcare Finding: Only 3 of 1,357 FDA-Cleared AI Medical Devices Tested Patient Outcomes, PLOS Digital Health Study Reveals Regulatory Gap

Shocking Healthcare Finding: Only 3 of 1,357 FDA-Cleared AI Medical Devices Tested Patient Outcomes, PLOS Digital Health Study Reveals Regulatory Gap

A study published in PLOS Digital Health in August 2026 reveals that of 1,357 FDA-authorized AI medical devices, only 3 (0.2%) evaluated patient health outcomes and only 34 (2.5%) were linked to prospective clinical trials, exposing a massive gap between regulatory approval and clinical validation that has alarmed the healthcare community.

Aug 30, 20264
Midjourney Medical Launches Full-Body Ultrasound Scanner: 60-Second 3D Body Maps, Targeting 50,000 Deployments by 2031, Pending FDA Clearance

Midjourney Medical Launches Full-Body Ultrasound Scanner: 60-Second 3D Body Maps, Targeting 50,000 Deployments by 2031, Pending FDA Clearance

Midjourney Medical launched a full-body ultrasound scanner prototype in June 2026 that generates 3D body maps in 60 seconds using $74M licensed Ultrasound-on-Chip technology, targeting 50,000 global deployments by 2031, but currently lacks FDA diagnostic clearance and is initially positioned as a body composition mapping service.

Aug 29, 20264
GRAIL Galleri Multi-Cancer Early Blood Test: FDA Advisory Committee Review Set for September 23, Backed by 70,000-Person Clinical Trial Data

GRAIL Galleri Multi-Cancer Early Blood Test: FDA Advisory Committee Review Set for September 23, Backed by 70,000-Person Clinical Trial Data

The U.S. FDA announced an advisory committee meeting for September 23, 2026, to review GRAIL's Galleri multi-cancer early detection blood test PMA application. Galleri uses AI to analyze DNA methylation patterns in blood, detecting over 50 cancer types simultaneously, backed by a 70,000-person NHS randomized controlled trial.

Aug 28, 20264
AI Healthcare Diagnosis Breakthrough: Harvard Study, FDA-Approved 1250+ Devices, and Asia-Pacific Hospital Adoption

AI Healthcare Diagnosis Breakthrough: Harvard Study, FDA-Approved 1250+ Devices, and Asia-Pacific Hospital Adoption

In healthcare AI, winning is not about benchmark scores. It is about workflow integration, governance, and measurable ROI in real hospitals.

Aug 18, 202616
AI Medical Diagnosis in 2026: Accuracy, Regulation, and Asia-Pacific Adoption

AI Medical Diagnosis in 2026: Accuracy, Regulation, and Asia-Pacific Adoption

In 2026, AI diagnosis is not won by the best model score, but by workflow fit, accountability, and regulatory scalability across APAC.

May 2, 202612
The AI Drug Discovery Revolution: Shortening R&D Timelines and Cutting Costs

The AI Drug Discovery Revolution: Shortening R&D Timelines and Cutting Costs

AI drug discovery is not mainly about replacing scientists. It is about killing weak programs earlier, testing fewer bad molecules, and improving capital efficiency.

Apr 10, 202612